Abstract
Twenty-one 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones (4a-u) were synthesized and evaluated as HIV-1 inhibitors in vitro. Among all compounds, compounds 4n and 4p displayed the potent anti-HIV-1 activities with EC50 values of 3.48 and 8.61 μg/mL, and TI values of 34.08 and > 23.22, respectively. It demonstrated that, to a series of 2-(N-arylsulfonyl-6-methylindol-3-yl)-3-aryl-1,3-thiazolidin-4-one derivatives, introduction of R2 as 4-Cl and R3 as H or 3-Cl could afford the more promising and potent compounds.
Keywords: 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1, 3-thiazolidin-4-ones, Acquired immunodeficiency syndrome, Human immunodeficiency virus-1, AIDS
Letters in Drug Design & Discovery
Title:Synthesis of New 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones as HIV-1 Inhibitors In Vitro
Volume: 9 Issue: 4
Author(s): Rui-Ge Yang, Liu-Meng Yang, Ya-Zhen Ke, Ning Huang, Rui Zhang, Yong-Tang Zheng, Hui Xu
Affiliation:
Keywords: 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1, 3-thiazolidin-4-ones, Acquired immunodeficiency syndrome, Human immunodeficiency virus-1, AIDS
Abstract: Twenty-one 2-(N-arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones (4a-u) were synthesized and evaluated as HIV-1 inhibitors in vitro. Among all compounds, compounds 4n and 4p displayed the potent anti-HIV-1 activities with EC50 values of 3.48 and 8.61 μg/mL, and TI values of 34.08 and > 23.22, respectively. It demonstrated that, to a series of 2-(N-arylsulfonyl-6-methylindol-3-yl)-3-aryl-1,3-thiazolidin-4-one derivatives, introduction of R2 as 4-Cl and R3 as H or 3-Cl could afford the more promising and potent compounds.
Export Options
About this article
Cite this article as:
Rui-Ge Yang, Liu-Meng Yang, Ya-Zhen Ke, Ning Huang, Rui Zhang, Yong-Tang Zheng, Hui Xu , Synthesis of New 2-(N-Arylsulfonylindol-3-yl)-3-aryl-1,3-thiazolidin-4-ones as HIV-1 Inhibitors In Vitro, Letters in Drug Design & Discovery 2012; 9 (4) . https://dx.doi.org/10.2174/157018012799859936
DOI https://dx.doi.org/10.2174/157018012799859936 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
STAT 3 as a Target for Cancer Drug Discovery
Current Medicinal Chemistry New Perspectives for SARS-CoV-2 Rapid Detection
Coronaviruses Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Focused Microarray Analysis: Characterization of Phenomes by Gene Expression Profiling
Current Pharmacogenomics Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease
Current Vascular Pharmacology An Overview on COVID-19 Pandemic: from Discovery to Treatment
Infectious Disorders - Drug Targets Preface
Current Cardiology Reviews Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer
Current Gene Therapy Is There a Rendezvous for SARS-CoV-2 and Agmatine?
Coronaviruses Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
Current Drug Targets Status of Flavonols as P-Glycoprotein Inhibitors in Cancer Chemotherapy
Current Cancer Therapy Reviews Microalbuminuria and the Hypertensive Disorders of Pregnancy
Current Hypertension Reviews Recent Developments in the Medicinal Chemistry of Cannabimimetic Indoles, Pyrroles and Indenes
Current Medicinal Chemistry Prader-Willi Syndrome: Genetics, Phenotype, and Management
Current Psychiatry Reviews Emerging Technologies, Recent Developments, and Novel Applications for Drug Metabolite Identification
Current Drug Metabolism Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Evaluating the Potential of <i>Adathoda vasica</i> against Respiratory Infection caused by <i>Klebsiella pneumoniae</i>
Current Chinese Science